Levin Tomer
Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, New York 10022, USA.
Int J Soc Psychiatry. 2006 Jul;52(4):324-31. doi: 10.1177/0020764006065144.
A new name for schizophrenia, reflecting a biopsychosocial conceptualization, may have utility in educating patients and the public. If readily translatable, it would be of great value in transcultural psychiatry. It may be clinically beneficial to psychoeducation in evidence-based treatment modalities such as medication management, multifamily group psycho-education and cognitive therapy.
Neuro-Emotional Integration Disorder (NEID) is proposed as the biopsychosocial candidate term to replace schizophrenia. The following subtypes are proposed: defensive type replacing paranoid, motoric type replacing catatonic, Brief Neuro-Emotional-Integration Breakdown (B-NEIB) replacing brief psychotic episode, NEID-Time Limited replacing schizophreniform disorder. Schizoaffective disorder might be termed NEID-Bipolar type. Anti-psychotic medication would be termed NEI-Enhancing medication.
By emphasizing the neuropsychiatric basis of this 'highly treatable brain disorder' through its labeling, stigma may ultimately be reduced. Even if the term NEID is not ultimately adopted, the principles outlined here should be helpful in choosing a replacement term for 'schizophrenia'.